Our Mission

To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.

We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development.

We innovate by creating new medicines, as well as new methods of drug discovery and delivery. Through our global research and development (R&D) operations, we’re establishing a portfolio of innovative products changing Standard of Care, Antibotics,Antidiabetic,vaccines, and over-the-counter products that deliver value to patients, healthcare providers, and all our shareholders.

2030 Vision

Global Pharma Innovator with Competitive Advantage in Diabetes.
• To have Specialty area business centered on Diabetes and Cardiology business as the core business.
• To have enriched regional value products  aligned with regional market.
• To have innovative products and pipeline changing SOC.
• To realize shareholders’ value through highly efficient management.
• *Specialty area: Drugs mainly prescribed at Hospital and/or by Specialty practitioners.
• Regional value products: Products aligned with regional market.
• SOC: Standard of Care.